cryptococcal meningitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Cryptococcus neoformans, an encapsulated yeast, enters the host through inhalation, disseminating from the lungs to the central nervous system. The polysaccharide capsule inhibits phagocytosis, allowing the pathogen to evade the immune system and cross the blood-brain barrier.

• Secondary mechanism: Once in the cerebrospinal fluid, the yeast proliferates and releases glucuronoxylomannan, a capsular component that suppresses the immune response, leading to impaired lymphocyte proliferation and reduced cytokine production, critical for immune defense.

• Key complication: The accumulation of yeast cells and capsular polysaccharides increases intracranial pressure, causing cerebral edema. This can lead to severe neurological deficits, seizures, and potentially fatal outcomes if not promptly addressed.

Patient Profile

Demographics:

42-year-old male, construction worker

History:

• Key past medical history: HIV positive with a CD4 count of 50 cells/mm³, previous opportunistic infections including oral thrush and PCP pneumonia

• Current medications: Antiretroviral therapy (combination of tenofovir, emtricitabine, and efavirenz), prophylactic trimethoprim-sulfamethoxazole, fluconazole

• Allergies: Penicillin (causes rash)

Current Presentation:

• Chief complaint: Severe headache and altered mental status

• Key symptoms: Persistent fever, neck stiffness, photophobia, nausea, vomiting, and confusion

• Vital signs: Temperature 39.5°C (103.1°F), heart rate 120 bpm, respiratory rate 28 breaths per minute, blood pressure 85/60 mmHg, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following admission, the patient underwent a lumbar puncture to assess the cerebrospinal fluid (CSF) for cryptococcal antigen and to perform a culture. The CSF analysis revealed a markedly elevated opening pressure of 300 mmH2O, indicative of significant intracranial hypertension. The CSF was clear, with a white blood cell count of 25 cells/µL, predominantly lymphocytes, a low glucose concentration of 25 mg/dL, and a protein level of 150 mg/dL. Cryptococcal antigen testing returned positive with a high titer, confirming the diagnosis of cryptococcal meningitis. Concurrent blood cultures also tested positive for Cryptococcus neoformans, suggesting disseminated infection.

Imaging studies, including a brain MRI, showed evidence of diffuse cerebral edema, and small non-enhancing lesions in the basal ganglia, consistent with cryptococcomas. The combination of these findings indicates both a severe CNS infection and a systemic fungal burden. Laboratory tests displayed worsening renal function, with serum creatinine rising from 1.1 to 2.5 mg/dL, posing a challenge for antifungal management due to potential nephrotoxicity associated with amphotericin B, a cornerstone in the treatment regimen.

These diagnostic insights necessitate critical clinical decisions. The elevated intracranial pressure demands urgent intervention to prevent further neurological deterioration. Balancing the need for aggressive antifungal therapy with the patient's renal impairment requires careful selection and dosing of medications. The presence of cryptococcomas might influence the duration and intensity of treatment. The healthcare team must also consider the patient’s immunosuppressed state and potential drug interactions as they plan the next steps in managing this complex case.

Section 2

Change in Patient Status:

Within 48 hours of the initial diagnosis, the patient's condition began to deteriorate significantly. Despite the initiation of antifungal therapy with a liposomal formulation of amphotericin B to mitigate nephrotoxicity, the patient's neurological status worsened. The patient became increasingly lethargic and developed a fixed, dilated pupil on the left side, indicative of an acute rise in intracranial pressure. A repeat lumbar puncture was performed, revealing an opening pressure now exceeding 350 mmH2O, necessitating immediate intervention to prevent herniation. The healthcare team performed a series of therapeutic lumbar punctures to relieve the pressure, but the patient's responsiveness continued to decline.

Concurrently, the patient's renal function further deteriorated, with serum creatinine levels climbing to 3.8 mg/dL and a significant reduction in urine output, raising concerns of acute kidney injury secondary to both the infection and antifungal treatment. The nephrology consult suggested transitioning to an alternative antifungal, such as flucytosine, while closely monitoring renal parameters and adjusting doses accordingly. Additionally, the patient's serum electrolytes revealed a decline in sodium levels to 125 mmol/L, possibly linked to cerebral salt-wasting syndrome, complicating fluid management strategies. These changes required a delicate balance between managing the intracranial hypertension, maintaining renal function, and addressing the systemic infection, each demanding advanced clinical judgment and coordination among the multidisciplinary team.

Section 3

The healthcare team decided to focus on the patient’s declining neurological status and the critical management of intracranial pressure. Despite repeated lumbar punctures, the patient exhibited minimal improvement in responsiveness. A cranial CT scan was ordered to assess for cerebral edema or any structural changes. The scan revealed diffuse cerebral edema with early signs of transtentorial herniation. This necessitated immediate escalation of care, prompting the initiation of hypertonic saline therapy and mannitol to aggressively manage the intracranial hypertension. The neurosurgery team was consulted for potential surgical interventions, such as external ventricular drainage, should the medical management prove insufficient.

Concurrently, the nephrology team closely monitored the patient’s renal parameters, adjusting antifungal therapy as needed. Flucytosine was initiated with careful dosing adjustments based on the patient’s renal function tests, which were drawn every 12 hours. Despite these measures, the patient’s serum creatinine reached 4.2 mg/dL, and urine output remained critically low. The fluid management strategy was further complicated by the patient’s hyponatremia, which persisted despite cautious sodium replacement efforts. The endocrine team was brought in to evaluate the possible role of cerebral salt-wasting syndrome versus syndrome of inappropriate antidiuretic hormone secretion (SIADH), each necessitating a distinct treatment approach.

In the face of these complications, the multidisciplinary team held a case conference to reassess and refine the treatment plan. They emphasized the need for continuous monitoring and rapid response to any further changes in the patient’s status. The primary objectives were to stabilize the intracranial pressure, prevent further renal deterioration, and correct the electrolyte imbalances, all while ensuring the infection was being effectively addressed. The team acknowledged the complexity of the case required vigilant assessment and innovative problem-solving to navigate the intertwined challenges successfully.

Section 4

As the team continued to manage the patient's complex condition, a new complication emerged that demanded immediate attention. Despite aggressive measures to manage intracranial pressure, the patient's neurological status deteriorated further. The patient became unresponsive to verbal stimuli, with a Glasgow Coma Scale (GCS) score dropping to 6, indicating severe impairment. Vital signs showed a widening pulse pressure with a blood pressure of 190/70 mmHg, bradycardia with a heart rate of 48 bpm, and irregular respirations, suggesting Cushing's triad indicative of increased intracranial pressure. Pupillary examination revealed anisocoria with a fixed and dilated right pupil, raising concerns for worsening herniation.

The laboratory results revealed worsening renal function, with serum creatinine now at 5.0 mg/dL and a further decline in urine output to less than 200 mL in 24 hours, confirming oliguria. Electrolyte imbalances persisted, with a serum sodium level of 126 mmol/L despite ongoing sodium replacement, compounding the challenges of fluid management. The patient's osmolality was measured at 260 mOsm/kg, consistent with the diagnosis of SIADH, steering the treatment plan towards fluid restriction and cautious hypertonic saline administration.

In response to these developments, the neurosurgery team expedited the placement of an external ventricular drain to relieve intracranial pressure. Concurrently, the nephrology team initiated continuous renal replacement therapy (CRRT) to manage the acute kidney injury and fluid overload while allowing for precise control of electrolyte balance. The multidisciplinary team recognized the need for urgent and coordinated intervention to address the patient's precarious status, underscoring the importance of dynamic reassessment and adaptation of the treatment strategy to stabilize the patient and prevent further deterioration.

Section 5

Following the placement of the external ventricular drain (EVD) and the initiation of continuous renal replacement therapy (CRRT), the team closely monitored the patient's response. Initial assessment post-intervention showed a slight improvement in the Glasgow Coma Scale (GCS) score, which rose to 8, indicating some positive response to the reduction in intracranial pressure. However, the patient's vital signs remained concerning. Blood pressure readings were now fluctuating between 180/68 mmHg and 170/70 mmHg, with persistent bradycardia at 50 bpm. The irregular respirations stabilized slightly but continued to exhibit Cheyne-Stokes patterns, suggesting ongoing brainstem involvement. Despite these critical interventions, anisocoria persisted, with the right pupil remaining fixed and dilated, signaling potential irreversible damage from herniation.

New diagnostic results revealed further complications. A repeat CT scan of the brain indicated a midline shift, confirming the severity of the cerebral edema and the impending risk of further herniation. Laboratory tests continued to show electrolyte imbalances, with serum sodium slightly increasing to 130 mmol/L, indicating partial response to hypertonic saline therapy but necessitating continued vigilance. Additionally, the patient's lactate levels were elevated at 4.5 mmol/L, reflecting possible tissue hypoperfusion and metabolic stress. The CRRT showed initial success in managing the renal dysfunction, as urine output began to increase slightly, surpassing 300 mL in the latest 24-hour period, but renal function markers remained critically elevated.

The multidisciplinary team remained on high alert for new complications that could arise from the delicate balance of interventions. The potential for infection due to the EVD placement was a significant concern, prompting the initiation of broad-spectrum antibiotics. Furthermore, the team prepared for the possibility of requiring further neurosurgical interventions or adjustments to CRRT settings to optimize patient outcomes. The complex interplay of treatments, ongoing monitoring, and swift adaptation to changes in the patient's status underscored the critical need for advanced clinical reasoning and a coordinated, multidisciplinary approach to care.